Merck-Hansoh Deal for Oral GLP-1 Hurts Obesity Drug Developers

Seeking AlphaDec 18 10:49 ET

Altimmune Shares Surge on CEO's CNBC Appearance

InvestingDec 4 11:18 ET

Pure Storage Posts Upbeat Results, Joins Cross Country Healthcare, Marvell Technology, Stoke Therapeutics And Other Big Stocks Moving Higher On Wednesday

BenzingaDec 4 10:55 ET

Altimmune Stock Up More Than 25% in a Month: Here's Why

BarchartDec 2 10:38 ET

Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders

GlobeNewswireDec 2 07:30 ET

Amgen (AMGN.US) released mid-term data on the weight loss therapy MariTide, showing weight loss effects comparable to Novo Nordisk.

Amgen announced on Tuesday that its experimental weight loss therapy MariTide achieved significant results in Phase 2 trials.

Zhitong FinanceNov 26 08:38 ET